Skip to main content

Shulman John D's Form 4 filing

Petros Pharmaceuticals, Inc. (PTPI) · filed Nov 30, 2021

Accession no.
0001104659-21-144901
Filed
Nov 30, 2021, 2:49 PM ET
Trade date
Nov 29, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $1.50M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shulman John DCIK 0001208886Director, 10% Owner
JCP III SM Aiv, L.P.CIK 000183538610% Owner
Juggernaut Partners III GP, L.P.CIK 000183542110% Owner
Juggernaut Partners III GP, Ltd.CIK 000183543310% Owner
METP Holdings LLCCIK 000183631910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 29, 2021Common Stock, par value $0.0001 per sharePPurchaseAcquired+500,000$3.00+$1,500,0005,557,771Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 29, 2021Common StockPPurchaseAcquired+375,000$0.00$0375,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)